Arcturus Therapeutics Updates CFO Severance and Stock Option Terms
I'm PortAI, I can summarize articles.
Arcturus Therapeutics Holdings Inc. announced no changes to CFO Daniel Roberts' compensation terms. His employment agreement includes a base salary of $219,580, bonus eligibility up to 20%, and participation in various company benefit plans. This information was published via EDGAR by Arcturus Therapeutics and is for informational purposes only.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments